Skip to content
MedsAcross

Medicine

Heparin 5000 units/100 mL injection

Heparin · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Heparin 5000 units/100 mL injection is a generic prescription medicine for intravenous use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Protect from freezing. Store at 20°C to 25°C (68°F to 77°F).

Key facts

Active ingredient (INN)
Heparin
Brand
Sold under the generic name
Strength
5000 units/100 mL
Dosage form
Injection
Route
Intravenous
Packs
24 bags, 30 pouches, 20 pouches and 2 more
Manufacturers
Fresenius KabiHospiraB. Braun Medical
Origin register
US FDA, United States
Storage
Protect from freezing. Store at 20°C to 25°C (68°F to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
B01AB01 Heparin
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
24 August 2017
Identifiers
RxCUI 1658717, 1659195, 1659196 +1DailyMed set ID 0413f511-6b34-4c15-e48b-3fad08baacbe, cb1c1e7a-c9ca-4a07-8833-e45ce436d287, 8b030692-fc66-4c53-85aa-6f865e635618NDC 0409-0012, 63323-518, 0409-3150 +2Application NDA018916, NDA017029, NDA019953

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
24 bag in 1 case / 500 mL in 1 bag63323-518-77Fresenius Kabi24 August 2017
24 bag in 1 case / 500 mL in 1 bag63323-522-77Fresenius Kabi24 August 2017
30 pouch in 1 case / 1 bag in 1 pouch / 250 mL in 1 bag0409-0012-30Hospira27 February 2023
20 pouch in 1 case / 1 bag in 1 pouch / 500 mL in 1 bag0409-3150-20Hospira3 January 2023
24 container in 1 case / 500 mL in 1 container0264-3301-10B. Braun Medical18 July 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 9 February 1939Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Heparin

Clinical summary

Heparin is an anti-coagulant indicated for prophylaxis and treatment of venous thrombosis and pulmonary embolism,, among other approved uses. It is available as injection for intravenous and subcutaneous use. MedsAcross supplies Heparin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Heparin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Heparin 5000 units/100 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.